ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin

ABSTRACT: We explored the regulation of alternative splicing in a cell model of breast cancer resistance to doxorubicin, and the impact of the depletion of two splicing factors (ZRANB2 and SYF2) in this context.

ORGANISM(S): Homo sapiens

PROVIDER: GSE126365 | GEO | 2019/09/15

REPOSITORIES: GEO